At the 2015 American Society of Clinical Oncology (ASCO) Annual Meeting, Georgina Long, BSc, PhD, MBBS, FRACP, of the University of Sydney, Sydney, Australia, discusses current research into treatments that target mechanistic events in the development of melanoma, and how the results of such research can be applied in clinical practice.
Developing targeted therapies for melanoma
21 Aug 2015
Oncology
Rate this content's potential impact on patient outcomes
Average rating / 5. Vote count:
No votes so far! Be the first to rate this content.